Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simbrinza add-on to prostaglandin analog versus placebo in open-angle glaucoma or ocular hypertension
MOH_2017-07-30_000682Phase 4Not yet recruiting
- Sponsor
- Alcon Inc.
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing Simbrinza + prostaglandin analog with Placebo vehicle + prostaglandin analog (2 arms). Planned start Jul 2017; status: not yet recruiting.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on MOH_2017-07-30_000682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-07-30_000682.